Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank check company sponsored by Forbion Capital Partners, a Netherlands-based life sciences venture capital firm with a long track record in European biotech and healthcare investing. The SPAC completed its initial public offering in 2021 and is focused on identifying a business combination target within the life sciences and healthcare sector, with a particular emphasis on European opportunities. The company filed its annual report on Form 10-K with the SEC on March 30, 2023, covering the fiscal year ended December 31, 2022, reflecting its continued status as a pre-combination entity. For full filing history, deal status updates, and sponsor profile data on FRBN, sign up for SpacDesk.